Ownership
Private
Therapeutic Areas
OtherDermatology
Stage
Commercial
Modalities
Small moleculeSmall moleculeSmall moleculeOther

Mantecorp General Information

Manufactures betamethasone valerate, a topical corticosteroid with anti-inflammatory activity used in the treatment of recurrent aphthous stomatitis

Contact Information

Website
Primary Industry
[ "Healthcare Services", "Healthcare", "Pharma" ]
Corporate Office
,
Brazil

Drug Pipeline

betamethasone valerate
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Mantecorp's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Mantecorp Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Mantecorp's complete valuation and funding history, request access »

Mantecorp Investors

Publicly traded via parent company shareholders (Hypera Pharma).
Investor Type: Venture Capital
Holding: Minority